(Q45775555)

15 December 2017

title

Potential role for Nrf2 activation in the therapeutic effect of MG132 on diabetic nephropathy in OVE26 diabetic mice (English)

1 reference

15 December 2017

1 reference

11

1 reference

15 December 2017

author name string

Wenpeng Cui

1

1 reference

15 December 2017

Bing Li

2

1 reference

15 December 2017

Yang Bai

3

1 reference

15 December 2017

Xiao Miao

4

1 reference

15 December 2017

Qiang Chen

5

1 reference

15 December 2017

Weixia Sun

6

1 reference

15 December 2017

Yi Tan

7

1 reference

15 December 2017

Ping Luo

8

1 reference

15 December 2017

Chi Zhang

9

1 reference

15 December 2017

Shirong Zheng

10

1 reference

15 December 2017

Lining Miao

12

1 reference

15 December 2017

Lu Cai

13

1 reference

15 December 2017

publication date

6 November 2012

1 reference

15 December 2017

American Journal of Physiology - Endocrinology and Metabolism

published in

1 reference

15 December 2017

volume

304

1 reference

15 December 2017

issue

1

1 reference

15 December 2017

page(s)

E87-99

1 reference

15 December 2017

Deletion of angiotensin II type 1 receptor gene or scavenge of superoxide prevents chronic alcohol-induced aortic damage and remodelling

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Comprehensive proteomic and transcriptomic analysis reveals early induction of a protective anti-oxidative stress response by low-dose proteasome inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Diabetic cardiomyopathy and its prevention by metallothionein: experimental evidence, possible mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Increasing expression of heme oxygenase-1 by proteasome inhibition protects astrocytes from heme-mediated oxidative injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Structure and functions of the 20S and 26S proteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Nrf2 activators as attractive therapeutics for diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Inflammation and the metabolic syndrome: role of angiotensin II and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Protective effects of magnesium lithospermate B against diabetic atherosclerosis via Nrf2-ARE-NQO1 transcriptional pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Reactive oxygen species-regulated signaling pathways in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

The ubiquitin-proteasome proteolytic pathway in heart vs skeletal muscle: effects of acute diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Prevention of diabetic nephropathy in rats through enhanced renal antioxidative capacity by inhibition of the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Nontoxic proteasome inhibition activates a protective antioxidant defense response in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Alterations of proteasome activities in skeletal muscle tissue of diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Nrf2 and NF-κB modulation by sulforaphane counteracts multiple manifestations of diabetic neuropathy in rats and high glucose-induced changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Bardoxolone methyl and kidney function in CKD with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Cell lines with extended in vitro growth potential from human renal proximal tubule: characterization, response to inducers, and comparison with established cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

The proteasome inhibitor MG132 induces nuclear translocation of erythroid transcription factor Nrf2 and cyclooxygenase-2 expression in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Fluvastatin prevents nephropathy likely through suppression of connective tissue growth factor-mediated extracellular matrix accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Cardiac metallothionein synthesis in streptozotocin-induced diabetic mice, and its protection against diabetes-induced cardiac injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Proteasome inhibitors remarkably prevent translesion replication in cancer cells but not normal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Mechanism of the Nrf2/Keap1/ARE signaling system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Diabetic nephropathy in humans: pathologic diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Proteasome-dependent degradation of guanosine 5'-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

Development of late-stage diabetic nephropathy in OVE26 diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00430.2012

10.1152/AJPENDO.00430.2012

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

23132297

1 reference

15 December 2017